规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | DSR-6434 is a highly potent TLR7 agonist with EC50 value of 7.2nM for activation of hTLR7 in NF-κB SEAP reporter assay. Administration of DSR-6434, i.v., inhibited lung metastasis by 78% at dose of 0.1mg/kg and suppressed lung metastasis completely at dose of 1 mg/kg on HM-1 metastasis model. DSR-6434 at concentration<5μM alone does not affect tumor cell( CT26 or KHT) clonogenic potential or radio sensitivity in vitro. Intravenous administration of 0.1mg/kg DSR-6434 in combination with IR improved survival in syngeneic models of colorectal carcinoma and fibrosarcoma in vivo, which may due to priming an antitumor CD8+ T-cell response. |
作用机制 | DSR-6434 possesses 8-oxoadenine structure which is a novel structural class IFN inducer.[1] |
Dose | Mice: 0.01 mg/kg, 0.1 mg/kg[2] (i.v.) |
Administration | i.v. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.50mL 0.50mL 0.25mL |
12.49mL 2.50mL 1.25mL |
24.97mL 4.99mL 2.50mL |
CAS号 | 1059070-10-8 |
分子式 | C19H28N8O2 |
分子量 | 400.48 |
SMILES Code | O=C2N(CC3=CC=C(OCCN(C)C)N=C3)C1=NC(NCCCC)=NC(N)=C1N2 |
MDL No. | MFCD30182245 |
别名 | |
运输 | 蓝冰 |
InChI Key | SSZHESNDOMBSRV-UHFFFAOYSA-N |
Pubchem ID | 25071151 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
溶解方案 |
DMSO: 120 mg/mL(299.64 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|